Thiophene carboxamides as inhibitors of the enzyme IKK-2

Details for Australian Patent Application No. 2004203967 (hide)

Owner AstraZeneca AB

Inventors Morley, Andrew David; Poyser, Jeffrey Philip

Agent Freehills

Pub. Number AU-B-2004203967

PCT Pub. Number WO2004/063185

Priority 0300091-6 15.01.03 SE

Filing date 13 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 1 March 2007

International Classifications

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/063185 Priority application(s): WO2004/063185

1 March 2007 Application Accepted

  Published as AU-B-2004203967

28 June 2007 Standard Patent Sealed

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004203969-Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

2004203966-Defensin proteins